NaturalProductMech

puromycin

CHEBI:17939 EXACT SEEDED antibacterialcytotoxicenzyme inhibitortoxin

An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome.

Structure

Standard InChIKeyRXWNCPJZOCPEPQ-NVWDDTSBSA-N
SMILES[H][C@](N)(CC1=CC=C(OC)C=C1)C(=O)N[C@@H]1[C@@H](CO)O[C@H]([C@@H]1O)N1C=NC2=C1N=CN=C2N(C)C
Stereochemistryfully defined
Cross-referencesnpatlas:NPA02054, pubchem:439530

Filing pathway

Carbohydrates — computed by NPClassifier npclassifier.gnps2.org@2026-09-07, which is why it is pinned rather than recomputed. The gene cluster's asserted class is other, from MIBiG.

Producer organisms 1

A claim that this taxon makes the compound. The basis says what the evidence addressed — a knockout and a database assertion are not the same claim.

TaxonBasisClusterEvidence
Streptomyces alboniger
NCBITaxon:132473
SOURCE_ASSERTION mibig:BGC0000878 PMID:8576156

Occurrences 11

Somebody found the compound in this organism and cited it. That is not a claim that the organism makes it, and nothing here promotes one to the other.

TaxonSourceReference
Streptomyces
NCBITaxon:1883
LOTUS DOI:10.1021/ACS.JNATPROD.7B00850
Streptomyces lividans
NCBITaxon:1916
LOTUS DOI:10.1016/S0014-5793(97)01564-0
Acronychia pubescens
NCBITaxon:273126
LOTUS DOI:10.1021/ACS.JNATPROD.8B00956
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.1016/S0014-5793(97)01564-0
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.1016/S0014-5793(98)01228-9
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.1021/BI00348A036
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.1074/JBC.271.3.1579
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.1111/J.1432-1033.1993.TB18454.X
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.1128/AAC.8.6.721
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.1128/JB.175.22.7474-7478.1993
Streptomyces alboniger
NCBITaxon:132473
LOTUS DOI:10.7164/ANTIBIOTICS.38.1761

Biosynthetic gene clusters 1

AccessionHostLocus evidenceGenome
mibig:BGC0000878 Streptomyces alboniger
NCBITaxon:132473
CLUSTER_UNSTATED genbank:X92429.1

A locus claim and a taxon claim are different questions. Heterologous expression settles the first and leaves the second where the isolation report left it.

Bioactivities 25

AssayResultReference
Constitutive androstane receptor (CAR) small molecule agonists, cell-based qHTS assay in HepG2 cells2.31 uMpubchem.aid:2202728
Constitutive androstane receptor (CAR) small molecule agonists, cell-based qHTS assay in HepG2 cells2.31 uMpubchem.aid:2202728
Cytochrome P450 family 2 subfamily C member 9 (CYP2C9) small molecule antagonists: luciferase cell-based qHTS assay23.9185 uMpubchem.aid:1645842
Cytochrome P450 family 3 subfamily A member 4 (CYP3A4) small molecule antagonists: luciferase cell-based qHTS assay9.5221 uMpubchem.aid:1645841
Cytochrome P450 family 3 subfamily A member 7 (CYP3A7) small molecule antagonists: luciferase cell-based qHTS assay23.9185 uMpubchem.aid:1963596
Cytochrome P450 family 3 subfamily A member 7 (CYP3A7) small molecule antagonists: luciferase cell-based qHTS assay23.9185 uMpubchem.aid:1963596
GF-AFC viability counterscreen for inhibitors of alpha-synuclein gene (SNCA) expression21.1923 uMpubchem.aid:1671193
P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen29.0929 uMPMID:31515284
Primary fluorescence-based thiol-reactive (MSTI) qHTS assay for identification of artifact compounds.13.3714 uMpubchem.aid:1845221
Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an RCH-ACV wild type WT cells (2C)0.2582 uMpubchem.aid:1645877
Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an RCH-ACV wild type WT cells (2C)0.2582 uMpubchem.aid:1645877
Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an isogenic RCH-ACV NSD2 p.E1099K mutant (9B)0.4093 uMpubchem.aid:1645876
Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an isogenic RCH-ACV NSD2 p.E1099K mutant (9B)0.4093 uMpubchem.aid:1645876
Primary qHTS for small molecule compounds that upregulate eGFP-tagged delta133p53alpha (in N-terminal) cells.6.7456 uMpubchem.aid:2060322
Primary qHTS for small molecule compounds that upregulate eGFP-tagged delta133p53alpha (in N-terminal) cells.6.7456 uMpubchem.aid:2060322
Primary qHTS to identify anti-liver cancer compounds using libraries of approved drugs and bioactive compounds1.2589 uMpubchem.aid:2202548
Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) drug resistant MV4-11 cells0.1836 uMpubchem.aid:1963824
Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) drug resistant MV4-11 cells0.1836 uMpubchem.aid:1963824
Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) naive MV4-11 cells0.2311 uMpubchem.aid:1963823
Viability qHTS for spleen associated tyrosine kinase inhibitor (SYKi) naive MV4-11 cells0.2311 uMpubchem.aid:1963823
Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput ScreeningACTIVEPMID:31498718
GENE-TOX mutagenicity studiesACTIVEpubchem.aid:1259408
High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37RvACTIVEpubchem.aid:1332
Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITFACTIVEpubchem.aid:2240
Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33ACTIVEpubchem.aid:2330

Elsewhere in the fleet

Provenance

Source conceptSourceVersion
BGC0000878MIBIG5
CHEBI:17939CHEBI3-star

This page is generated from data/natural_products/carbohydrates/puromycin.yaml, which is generated from the committed inventories. Neither is edited by hand.